This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignees: Hikal Limited, Indian Institute of Science. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 7 
1 out of 145 
Years Active: 2009
Title: Ananda Kuppanna: Innovator in Pharmaceutical Chemistry
Introduction
Ananda Kuppanna is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on gabapentin analogues. His research has implications for the development of new therapeutic compounds.
Latest Patents
Kuppanna holds a patent for "Gabapentin analogues and process thereof." This invention relates to the compounds trans (E) and cis (Z) stereoisomers of 4-t-butyl gabapentin, represented by formulas (11) and (12). The patent outlines a process for the preparation of these stereoisomers, which can be crucial for advancing medical treatments.
Career Highlights
Throughout his career, Ananda Kuppanna has worked with prominent organizations such as Hikal Limited and the Indian Institute of Science. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to various research initiatives.
Collaborations
Kuppanna has collaborated with notable colleagues, including Nagarajan Kuppuswamy and Sivaramakrishnan Hariharan. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Ananda Kuppanna's work in pharmaceutical chemistry exemplifies the importance of innovation in developing new therapeutic agents. His contributions, particularly in the area of gabapentin analogues, highlight the potential for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile